High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.
about
Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil.Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study.Adverse Effects of Direct Acting Antivirals in HIV/HCV Coinfected Patients: A 4-Year Experience in Miami, Florida.Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy: The STIly observational study
P2860
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
High efficacy of Sofosbuvir pl ...... fected with genotypes 1 and 4.
@en
type
label
High efficacy of Sofosbuvir pl ...... fected with genotypes 1 and 4.
@en
prefLabel
High efficacy of Sofosbuvir pl ...... fected with genotypes 1 and 4.
@en
P2093
P2860
P356
P1433
P1476
High efficacy of Sofosbuvir pl ...... fected with genotypes 1 and 4.
@en
P2093
Adolfo Gallego
Alejandro Blasco
Alexandra Gómez
Ana C Arencibia
Carme Baliellas
Carmen López-Núñez
Francisco Gea-Rodríguez
Gloria Sánchez-Antolín
Inmaculada Fernández
Isidoro Narváez
P2860
P356
10.1111/LIV.13470
P577
2017-05-08T00:00:00Z